The alphaVbeta6 integrin as a novel molecular target for colorectal cancer

Richard C Bates1

  • 1University of Massachusetts Medical School, Department of Cancer Biology, Worcester, MA 01605-2324 USA. Richard.bates@umassmed.edu

Insights

AlphaVbeta6 integrin is upregulated in colorectal cancer, impacting tumor progression and patient outcomes. This finding highlights alphaVbeta6 as a potential therapeutic target for novel colorectal cancer treatments.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Colorectal cancer (CRC) treatment is advancing with molecular targeting strategies.
  • Integrin receptors are key targets due to their roles in tumor growth, angiogenesis, and metastasis.
  • AlphaVbeta6 integrin (αVβ6) is upregulated in CRC progression.

Purpose of the Study:

  • To investigate the role of alphaVbeta6 integrin in colorectal cancer.
  • To evaluate alphaVbeta6 as a prognostic and predictive marker in early-stage CRC.
  • To explore alphaVbeta6 as a potential therapeutic target for CRC.

Main Methods:

  • Analysis of alphaVbeta6 integrin expression in a colorectal tumor progression model.
  • Assessment of the prognostic and predictive value of alphaVbeta6 expression.
  • Evaluation of alphaVbeta6's biologic functions and expression patterns.

Main Results:

  • AlphaVbeta6 integrin was found to be upregulated in a model of colorectal tumor progression.
  • Elevated alphaVbeta6 expression impacts tumor cell function.
  • AlphaVbeta6 expression serves as a prognostic variable and predicts patient outcome in early-stage CRC.

Conclusions:

  • AlphaVbeta6 integrin plays a significant role in colorectal cancer progression.
  • AlphaVbeta6 is a valuable prognostic and predictive biomarker for CRC.
  • AlphaVbeta6 represents a novel therapeutic candidate for colorectal cancer treatment.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.